The Spectacular Fall of 23andMe

This podcast episode dives into the complexities of 23andMe's journey, from its early success and rapid rise to its subsequent challenges and financial struggles. The episode highlights the company's early market dominance, its pivot from ancestry to healthcare, the launch of personalized health reports, and the challenges of drug development. Along the way, listeners will learn about the importance of profitability, the misleading nature of hype and virality, and the need for a focused approach in the biotechnology industry.